SILVERARC CAPITAL MANAGEMENT, LLC Prometheus Biosciences, Inc. Transaction History

SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:

$12.07M
portfolio value

Prometheus Biosciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 put Decrease -32.15% -97K shares 3.56M $59.01 204.7K
Q2 2022 put Increase 0.00% 301.7K shares 8.51M $28.23 301.7K
Q2 2021 share Decrease -100.00% -15K shares -274K $24.56 0
Q1 2021 share Increase 0.00% 15K shares 274K $18.26 15K